These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 393288

  • 1. Treatment of severe hypertension by repeated bolus injections of labetalol.
    Cumming AM, Brown JJ, Lever AF, Mackay A, Robertson JI.
    Br J Clin Pharmacol; 1979; 8(Suppl 2):199S-204S. PubMed ID: 393288
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Effects of labetalol, a new alpha- and beta-adrenoreceptor blocking drug, on arterial pressure, renal function and renin activity (author's transl)].
    Zech P, Pozet N, Sassard J, Vincent M.
    Nouv Presse Med; 1980 Mar 29; 9(15):1087-90. PubMed ID: 7008020
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intravenous labetalol in severe hypertension. Effects on blood pressure, plasma renin activity and catecholamines.
    Lechi A, Picotti GB, Covi G, Pomari S, Pedrolli E, Cesura AM, Danti G, Mattioli M.
    Arzneimittelforschung; 1981 Mar 29; 31(3):524-6. PubMed ID: 7013770
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-term treatment of hypertension with labetalol.
    Prichard BN, Boakes AJ, Hernández R.
    Br J Clin Pharmacol; 1979 Mar 29; 8(Suppl 2):171S-177S. PubMed ID: 526398
    [Abstract] [Full Text] [Related]

  • 14. Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol.
    Rosei EA, Brown JJ, Lever AF, Robertson AS, Robertson JI, Trust PM.
    Br J Clin Pharmacol; 1976 Aug 29; 3(4 Suppl 3):809-15. PubMed ID: 990158
    [Abstract] [Full Text] [Related]

  • 15. Acute effect of intravenous labetalol in the treatment of systemic arterial hypertension.
    Ronne-Rasmussen JO, Andersen GS, Jensen NB, Andersson E.
    Br J Clin Pharmacol; 1976 Aug 29; 3(4 Suppl 3):805-8. PubMed ID: 990157
    [Abstract] [Full Text] [Related]

  • 16. [Use of labetalol in the treatment of hypertensive crises].
    Semplicini A, Pessina AC, Rossi GP, Palatini P, Hlede M, Morandin F, Visonà A, Mazzucato A, Dal Palù C.
    G Ital Cardiol; 1982 Aug 29; 12(5):355-8. PubMed ID: 7152187
    [Abstract] [Full Text] [Related]

  • 17. Comparison of labetalol, clonidine and diazoxide intravenously administered in severe hypertension.
    Yeung CK, Thomas GW, Whitworth JA, Kincaid-Smith P.
    Med J Aust; 1979 Nov 03; 2(9):499-500. PubMed ID: 522807
    [Abstract] [Full Text] [Related]

  • 18. Labetalol in resistant hypertension.
    Dargie HJ, Dollery CT, Daniel J.
    Br J Clin Pharmacol; 1976 Aug 03; 3(4 Suppl 3):751-5. PubMed ID: 990154
    [Abstract] [Full Text] [Related]

  • 19. The hypotensive effect of a single daily dose of labetalol: a preliminary study.
    Rossi A, Ziacchi V, Lomanto B.
    Int J Clin Pharmacol Ther Toxicol; 1982 Sep 03; 20(9):438-45. PubMed ID: 6754634
    [Abstract] [Full Text] [Related]

  • 20. [Combined captopril and labetalol treatment of malignant arterial hypertension (author's transl)].
    El Matri A, Kechrid C, Larabi M, Belkahia C, Ben Ayed H.
    Nouv Presse Med; 1981 Apr 30; 10(19):1575-8. PubMed ID: 7025848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.